| Literature DB >> 28157540 |
John Y W Lee1, Chao-Kai Hsu2, Magdalene Michael3, Arti Nanda4, Lu Liu5, James R McMillan5, Celine Pourreyron6, Takuya Takeichi7, Jakub Tolar8, Evan Reid9, Thomas Hayday3, Sergiu C Blumen10, Saif Abu-Mouch11, Rachel Straussberg12, Lina Basel-Vanagaite13, Yael Barhum14, Yasmin Zouabi15, Hejab Al-Ajmi4, Hsin-Yu Huang16, Ting-Chien Lin16, Masashi Akiyama17, Julia Y Y Lee16, W H Irwin McLean18, Michael A Simpson19, Maddy Parsons3, John A McGrath20.
Abstract
SPG23 is an autosomal-recessive neurodegenerative subtype of lower limb spastic paraparesis with additional diffuse skin and hair dyspigmentation at birth followed by further patchy pigment loss during childhood. Previously, genome-wide linkage in an Arab-Israeli pedigree mapped the gene to an approximately 25 cM locus on chromosome 1q24-q32. By using whole-exome sequencing in a further Palestinian-Jordanian SPG23 pedigree, we identified a complex homozygous 4-kb deletion/20-bp insertion in DSTYK (dual serine-threonine and tyrosine protein kinase) in all four affected family members. DSTYK is located within the established linkage region and we also found the same mutation in the previously reported pedigree and another Israeli pedigree (total of ten affected individuals from three different families). The mutation removes the last two exons and part of the 3' UTR of DSTYK. Skin biopsies revealed reduced DSTYK protein levels along with focal loss of melanocytes. Ultrastructurally, swollen mitochondria and cytoplasmic vacuoles were also noted in remaining melanocytes and some keratinocytes and fibroblasts. Cultured keratinocytes and fibroblasts from an affected individual, as well as knockdown of Dstyk in mouse melanocytes, keratinocytes, and fibroblasts, were associated with increased cell death after ultraviolet irradiation. Keratinocytes from an affected individual showed loss of kinase activity upon stimulation with fibroblast growth factor. Previously, dominant mutations in DSTYK were implicated in congenital urological developmental disorders, but our study identifies different phenotypic consequences for a recurrent autosomal-recessive deletion mutation in revealing the genetic basis of SPG23.Entities:
Keywords: DSTYK; Spastic Paraplegia 23; autosomal-recessive; deletion; gene; hereditary spastic paraplegia; mutation; pigmentation; vitiligo; whole-exome sequencing
Mesh:
Substances:
Year: 2017 PMID: 28157540 PMCID: PMC5294675 DOI: 10.1016/j.ajhg.2017.01.014
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025